What Are The Recommended Operational Parameters When Using A 10,600 Nm Co2 Ablative Laser System To Treat Epidermal Nevi And Seborrheic Keratoses? Discover Safe And Effective Settings.

For trained clinicians, a reasonable starting protocol is low-power, superpulsed CO₂ ablation at 5–10 Hz, with power selected according to lesion thickness and anatomical sensitivity. Typical power is 0.2–1.5 W, with 0.3–1.0 W commonly used on facial or auricular lesions; thicker lesions may require up to approximately 2.0 W. Treatment should be performed under appropriate local anesthesia, with controlled layer-by-layer ablation rather than indiscriminate deep vaporization.

Use the lowest power that achieves complete superficial ablation while limiting treatment to the papillary dermis. The ranges below are reference starting points—not universal prescriptions—because spot size, pulse duration, handpiece design, tissue thickness, and the individual laser’s calibration substantially affect delivered energy.

Core Operating Parameters

Wavelength and emission mode

Use a 10,600 nm CO₂ laser in superpulsed emission mode with an ablative-thermal pulse profile.

The high water absorption of this wavelength allows controlled vaporization of keratinized epidermal tissue. Superpulsing is intended to reduce unnecessary residual heat compared with longer, continuous thermal exposure.

Power range

A practical general range is 0.2–1.5 W.

For facial, auricular, or relatively thin lesions, a common working range is 0.3–1.0 W. For thicker or more hyperkeratotic lesions, power may be increased progressively toward 1.5–2.0 W, provided the clinical endpoint and surrounding-tissue temperature remain controlled.

Pulse frequency

Use a repetition frequency of approximately 5–10 Hz.

A lower frequency, such as 5 Hz, is more conservative for delicate or anatomically constrained areas. Frequencies toward 10 Hz may be useful for efficient treatment of broader or thicker lesions, but they increase the importance of avoiding pulse overlap and heat accumulation.

Anesthesia

Local anesthesia is generally appropriate, particularly for larger, thicker, or sensitive lesions.

Anesthesia should not be used to justify aggressive ablation; it can reduce feedback from the patient while thermal injury is accumulating.

Adjusting Parameters by Lesion and Site

Facial and auricular epidermal lesions

For facial or auricular epidermal nevi and seborrheic keratoses, begin conservatively at approximately 0.3–1.0 W, using superpulsed ablative-thermal pulses at 5–10 Hz.

Thin lesions and cosmetically sensitive areas generally favor the lower end of the range. Auricular lesions with substantial papillomatosis may require gradual increases, but the operator should reassess after each pass rather than selecting the maximum setting initially.

Thicker scalp or forehead lesions

Thicker hyperkeratotic lesions may be treated within approximately 0.3–1.5 W, with selected cases requiring higher output within the system’s validated operating range.

The key is staged removal: ablate a superficial layer, clear the residue, inspect the base, and then determine whether additional treatment is necessary.

Periocular or conjunctival-border lesions

Periocular lesions require a substantially more conservative approach because eyelid, ocular-surface, and adjacent adnexal structures are vulnerable to thermal injury.

Reference protocols describe approximately 0.1–0.5 W, often near 0.2–0.3 W at 5 Hz, but these values should not be transferred automatically between laser platforms. Treatment near the conjunctival border should be undertaken only by an appropriately trained specialist using dedicated ocular protection and a protocol validated for that device and location.

Treating Epidermal Nevi Layer by Layer

Initial debulking

For papillomatous or verrucous epidermal nevi, the initial objective is to remove the prominent epidermal component without extending unnecessarily into the dermis.

Some protocols describe a larger spot, such as approximately 3 mm, with pulse energies around 450–500 mJ for initial debulking. These energy values are not interchangeable with watts or with settings on another laser, because pulse duration, spot size, and delivery mode determine the actual tissue effect.

Residual papillomatosis

After wiping away denatured tissue, inspect the surface under magnification.

If residual papillary projections remain, some protocols use a smaller spot, such as approximately 1 mm, with lower pulse energies around 150–250 mJ in focused or defocused modes. These figures require device-specific validation and should not be used without understanding the system’s pulse characteristics.

Clinical endpoint

The intended endpoint is loss of the papillated surface with ablation limited to the papillary dermis.

A mildly yellow or desiccated dermal appearance may be used as a visual treatment cue in some protocols, but it is not a universal safety endpoint. Excessive whitening, charring, deepening, or persistent thermal change suggests over-treatment and should prompt cessation and reassessment.

Treating Seborrheic Keratoses

Superficial lesions

For thin seborrheic keratoses, use the lower portion of the general range—approximately 0.2–0.8 W, superpulsed, at 5–10 Hz.

The lesion should be vaporized progressively until the hyperkeratotic component is removed and the treatment endpoint is reached, while avoiding repeated passes over the same area without reassessment.

Thick or broad lesions

For thicker lesions, approximately 0.3–1.5 W may be appropriate, with power adjusted to the lesion’s thickness and anatomical site.

A staged technique is preferable to a single aggressive pass. This reduces the risk of excessive thermal injury, scarring, prolonged erythema, and pigmentary change.

Pre-treatment diagnosis

A lesion should not be ablated solely because it resembles a seborrheic keratosis.

Clinical and dermatoscopic evaluation should precede treatment, and biopsy or specialist assessment is appropriate when the diagnosis is uncertain, the lesion is atypical, changing, bleeding, inflamed, or otherwise suspicious.

Treatment Technique and Aftercare

Preventing cumulative heat

Use controlled passes, avoid excessive pulse overlap, and allow time for tissue inspection between passes.

The same nominal power can produce very different results depending on spot size, pulse duration, scanning speed, and whether the beam is focused or defocused.

Eye and plume protection

Use wavelength-appropriate ocular protection, particularly around facial and periocular lesions.

CO₂ ablation also creates surgical plume. Appropriate smoke evacuation, respiratory protection, and infection-control measures are necessary in addition to routine laser safety precautions.

Dressings and follow-up

A nonadherent or moist wound-care strategy may be used according to the treating clinician’s protocol. Some facial seborrheic keratosis protocols use a hydrocolloid film dressing after complete vaporization.

Re-epithelialization and lesion clearance are variable. Follow-up may occur around 15–30 days for early healing assessment, with cosmetic and recurrence evaluation extending to approximately 30–90 days, rather than assuming a fixed healing time.

Understanding the Trade-offs

Higher power is not automatically more effective

Increasing power may speed ablation of thick tissue, but it also increases the risk of dermal injury, scarring, prolonged erythema, and post-inflammatory hyperpigmentation or hypopigmentation.

For cosmetically sensitive areas, a slower, staged approach is usually safer than aggressive vaporization.

Wattage alone is insufficient

Power in watts does not fully define the treatment dose.

Pulse duration, pulse energy, spot diameter, repetition rate, beam focus, scanning technique, and tissue dwell time must all be considered. A protocol expressed only in watts and hertz cannot be safely copied to another device without confirming equivalent pulse specifications.

Epidermal nevi may recur

Ablation can produce good cosmetic clearance, but epidermal nevi may recur if deeper or residual nevus components remain.

The operator should balance clearance against the risk of extending beyond the papillary dermis, particularly in congenital, extensive, or deeply verrucous lesions.

Periocular treatment carries special risk

The conservative ranges cited for periocular lesions do not eliminate the risk of ocular-surface injury, eyelid distortion, scarring, or pigmentary change.

Lesions at the conjunctival border or near the eye should not be managed using routine facial settings.

How to Apply This to Your Project

The final settings should be confirmed against the specific laser’s manual, validated clinical protocol, and the operator’s training. Use these ranges as a framework for conservative parameter selection:

If your primary focus is a thin facial or auricular lesion: Begin near 0.3–1.0 W, superpulsed, at 5–10 Hz, and reassess after each controlled pass.
If your primary focus is a thick scalp, forehead, or verrucous lesion: Consider approximately 0.3–1.5 W, with cautious escalation toward 2.0 W only when justified by lesion thickness and device-specific guidance.
If your primary focus is a periocular or conjunctival-border lesion: Use a specialist periocular protocol, typically in the 0.1–0.5 W range and often near 5 Hz, with dedicated ocular protection and no direct transfer of generic facial settings.
If your primary focus is minimizing scarring and pigmentary change: Limit ablation to the superficial lesion and papillary dermis, use staged passes, and stop at the appropriate clinical endpoint rather than pursuing maximal vaporization.

The safest CO₂ laser protocol is the lowest device-validated dose that achieves the desired superficial endpoint without unnecessary dermal or ocular injury.

Summary Table:

Parameter	Recommended Range
Wavelength	10,600 nm
Emission Mode	Superpulsed
Power	0.2–1.5 W (facial/auricular: 0.3–1.0 W; thick lesions: up to 2.0 W)
Frequency	5–10 Hz
Anesthesia	Local anesthesia as needed
Clinical Endpoint	Loss of papillated surface, ablation limited to papillary dermis
Aftercare	Nonadherent or moist wound care; follow-up at 15–30 days and 30–90 days

Ready to Enhance Your Aesthetic Practice?

At BELIS, we specialize in providing professional-grade medical aesthetic equipment exclusively for clinics and premium salons. Our advanced laser systems, including CO2 fractional lasers, are designed to deliver safe and effective treatments for epidermal nevi, seborrheic keratoses, and more. With our comprehensive product range and expert support, we help you achieve optimal patient outcomes and business growth. Whether you are looking for high-quality devices, OEM/ODM services, or reliable supply, our team is here to assist you.

Contact us today to learn how BELIS can elevate your practice with cutting-edge laser technology and tailored solutions!